Bicara Therapeutics to Participate in Upcoming Investor Conferences

BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that management will participate in multiple upcoming investor conferences: Cantor Global Healthcare Conference 2025Date and Time: Wednesday, September 3, 2025 at 10:55 a.m. ET 2025 Wells Fargo Healthcare ConferenceDate and Time: Wednesday, September 3, 2025 at 2:15 p.m. ET Morg ...